# A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex

> **NCT00002246** · PHASE3 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 20 (—)

## Conditions studied

- AIDS Dementia Complex
- HIV Infections

## Interventions

- **DRUG:** Stavudine

## Key facts

- **NCT ID:** NCT00002246
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-10
- **Primary completion:** 1999-03
- **Final completion:** 1999-03
- **Target enrollment:** 20 (—)
- **Last updated:** 2011-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002246, "A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00002246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
